Replies to post #9333 on GTC Biotherapeutics (fka GTCB)

[DewDiligence]

>From my research, it appears that GlycoFi biggest advantage is the speed at which they can now create a new glycoproteins.<

It’s been more than two years since MRK and GlycoFi began working together on drug development (#msg-8836716) but, to my knowledge, no drug employing GlycoFi’s technology has been advanced into clinical trials.

Perhaps you have an exaggerated view of the program-development speed.